128 related articles for article (PubMed ID: 23207573)
21. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W
J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.
Narendran R; Mason NS; Chen CM; Himes M; Keating P; May MA; Rabiner EA; Laruelle M; Mathis CA; Frankle WG
Synapse; 2011 Oct; 65(10):991-7. PubMed ID: 21360596
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of peripheral benzodiazepine receptor in the human brain using PET with (11)C-AC-5216.
Miyoshi M; Ito H; Arakawa R; Takahashi H; Takano H; Higuchi M; Okumura M; Otsuka T; Kodaka F; Sekine M; Sasaki T; Fujie S; Seki C; Maeda J; Nakao R; Zhang MR; Fukumura T; Matsumoto M; Suhara T
J Nucl Med; 2009 Jul; 50(7):1095-101. PubMed ID: 19525461
[TBL] [Abstract][Full Text] [Related]
24. Further evaluation of the carbon11-labeled D(2/3) agonist PET radiotracer PHNO: reproducibility in tracer characteristics and characterization of extrastriatal binding.
Egerton A; Hirani E; Ahmad R; Turton DR; Brickute D; Rosso L; Howes OD; Luthra SK; Grasby PM
Synapse; 2010 Apr; 64(4):301-12. PubMed ID: 19957364
[TBL] [Abstract][Full Text] [Related]
25. Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO.
Mizrahi R; Agid O; Borlido C; Suridjan I; Rusjan P; Houle S; Remington G; Wilson AA; Kapur S
Schizophr Res; 2011 Sep; 131(1-3):63-8. PubMed ID: 21684721
[TBL] [Abstract][Full Text] [Related]
26. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
[TBL] [Abstract][Full Text] [Related]
27. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
[TBL] [Abstract][Full Text] [Related]
28. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy.
Tziortzi AC; Searle GE; Tzimopoulou S; Salinas C; Beaver JD; Jenkinson M; Laruelle M; Rabiner EA; Gunn RN
Neuroimage; 2011 Jan; 54(1):264-77. PubMed ID: 20600980
[TBL] [Abstract][Full Text] [Related]
29. Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA.
Finnema SJ; Halldin C; Bang-Andersen B; Gulyás B; Bundgaard C; Wikström HV; Farde L
Synapse; 2009 May; 63(5):378-89. PubMed ID: 19173265
[TBL] [Abstract][Full Text] [Related]
30. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
Boileau I; Payer D; Chugani B; Lobo D; Behzadi A; Rusjan PM; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M
Addiction; 2013 May; 108(5):953-63. PubMed ID: 23167711
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
Kiss B; Horti F; Bobok A
Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
[TBL] [Abstract][Full Text] [Related]
32. Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors.
McCormick PN; Wilson VS; Wilson AA; Remington GJ
Pharmacol Res; 2013 Apr; 70(1):66-71. PubMed ID: 23327779
[TBL] [Abstract][Full Text] [Related]
33. Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.
Caravaggio F; Kegeles LS; Wilson AA; Remington G; Borlido C; Mamo DC; Graff-Guerrero A
Synapse; 2016 Nov; 70(11):453-60. PubMed ID: 27341789
[TBL] [Abstract][Full Text] [Related]
34. Non-linear mixed effects modelling of positron emission tomography data for simultaneous estimation of radioligand kinetics and occupancy in healthy volunteers.
Kågedal M; Cselényi Z; Nyberg S; Jönsson S; Raboisson P; Stenkrona P; Hooker AC; Karlsson MO
Neuroimage; 2012 Jul; 61(4):849-56. PubMed ID: 22425672
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET.
Ashworth S; Rabiner EA; Gunn RN; Plisson C; Wilson AA; Comley RA; Lai RY; Gee AD; Laruelle M; Cunningham VJ
J Nucl Med; 2010 Jul; 51(7):1021-9. PubMed ID: 20554726
[TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
[TBL] [Abstract][Full Text] [Related]
37. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
[TBL] [Abstract][Full Text] [Related]
38. In vivo imaging of cerebral dopamine D3 receptors in alcoholism.
Erritzoe D; Tziortzi A; Bargiela D; Colasanti A; Searle GE; Gunn RN; Beaver JD; Waldman A; Nutt DJ; Bani M; Merlo-Pich E; Rabiner EA; Lingford-Hughes A
Neuropsychopharmacology; 2014 Jun; 39(7):1703-12. PubMed ID: 24469594
[TBL] [Abstract][Full Text] [Related]
39. Effect of scan-time shortening on the
Matsunaga K; Tonomura M; Abe K; Shimosegawa E
Ann Nucl Med; 2023 Apr; 37(4):227-237. PubMed ID: 36656501
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [(11)C]-(+)-PHNO.
Girgis RR; Xu X; Gil RB; Hackett E; Ojeil N; Lieberman JA; Slifstein M; Abi-Dargham A
Schizophr Res; 2015 Oct; 168(1-2):373-6. PubMed ID: 26190300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
